- Home
- GNFT vs GF Comparison
GNFT vs GF Comparison
Compare GNFT & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- GF
- Stock Information
- Founded
- GNFT 1999
- GF 1990
- Country
- GNFT France
- GF Germany
- Employees
- GNFT N/A
- GF N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- GF Investment Managers
- Sector
- GNFT Health Care
- GF Finance
- Exchange
- GNFT Nasdaq
- GF Nasdaq
- Market Cap
- GNFT 216.7M
- GF 187.5M
- IPO Year
- GNFT 2019
- GF N/A
- Fundamental
- Price
- GNFT $3.97
- GF $11.74
- Analyst Decision
- GNFT Strong Buy
- GF
- Analyst Count
- GNFT 2
- GF 0
- Target Price
- GNFT $10.00
- GF N/A
- AVG Volume (30 Days)
- GNFT 8.5K
- GF 28.1K
- Earning Date
- GNFT 09-22-2025
- GF 01-01-0001
- Dividend Yield
- GNFT N/A
- GF 0.82%
- EPS Growth
- GNFT N/A
- GF N/A
- EPS
- GNFT N/A
- GF N/A
- Revenue
- GNFT $52,994,715.00
- GF N/A
- Revenue This Year
- GNFT $3.14
- GF N/A
- Revenue Next Year
- GNFT N/A
- GF N/A
- P/E Ratio
- GNFT N/A
- GF N/A
- Revenue Growth
- GNFT N/A
- GF N/A
- 52 Week Low
- GNFT $2.55
- GF $7.38
- 52 Week High
- GNFT $6.42
- GF $9.41
- Technical
- Relative Strength Index (RSI)
- GNFT 51.40
- GF 53.74
- Support Level
- GNFT $3.91
- GF $11.66
- Resistance Level
- GNFT $4.10
- GF $11.83
- Average True Range (ATR)
- GNFT 0.16
- GF 0.14
- MACD
- GNFT 0.02
- GF 0.04
- Stochastic Oscillator
- GNFT 61.40
- GF 73.38
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.